CCA
GRTS

Catalyst Capital Advisors’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Catalyst Capital Advisors’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-468
Closed -$7K – 490
2018
Q4 		$7K Hold
468
– – ﹤0.01% 334
2018
Q3 		$7K Buy
+468
New +$6.66K ﹤0.01% 370

Other funds holding GRTS

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Catalyst Capital Advisors's GRTS Position: Q1 2019 in Review

Catalyst Capital Advisors sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2019, closing a stake of 468 shares — an estimated $7K sold.

Catalyst Capital Advisors first reported a position in GRTS in Q3 2018 and held it in 2 quarters. The position peaked at $7K in Q4 2018. 54 funds tracked by Wall St. Rank hold GRTS as of Q1 2019.

  • Catalyst Capital Advisors reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Catalyst Capital Advisors sold 468 Gritstone bio, Inc. Common Stock shares in Q1 2019, an estimated $7K.
  • Catalyst Capital Advisors first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 2 quarters.
  • Catalyst Capital Advisors's Gritstone bio, Inc. Common Stock position peaked at $7K in Q4 2018.
  • 54 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2019.

Based on Catalyst Capital Advisors's 13F filing for Q1 2019, filed 8 May 2019.